Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipids for psychiatrists - an overview.

Ian S Young1

  • 1Centre for Clinical and Population Sciences, Queen's University Belfast, Belfast, UK. I.Young@qub.ac.uk

Journal of Psychopharmacology (Oxford, England)
|November 11, 2005
PubMed
Summary

High cholesterol levels increase cardiovascular disease risk. Lipid management, including statins and other drugs, is crucial for preventing and treating heart disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Measuring Potassium, Matrix Matters.

The journal of applied laboratory medicine·2026
Same author

Outside the Laboratory-A New Section in JALM.

The journal of applied laboratory medicine·2026
Same author

Sherlock Holmes Meets Dr. Watson.

The journal of applied laboratory medicine·2026
Same author

An overview of the UK Scientific Advisory Committee on Nutrition's assessments and recommendations on processed foods and sweeteners.

The British journal of nutrition·2026
Same author

The Past, the Present, and the Future for The Journal of Applied Laboratory Medicine.

The journal of applied laboratory medicine·2025
Same author

Updating the Scientific Advisory Committee on Nutrition's Framework for the evaluation of evidence - CORRIGENDUM.

The British journal of nutrition·2025

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Serum cholesterol is a significant risk factor for cardiovascular disease (CVD).
  • Elevated total cholesterol, LDL cholesterol, and triglycerides correlate with CVD risk.
  • HDL cholesterol exhibits an inverse relationship with CVD risk.

Purpose of the Study:

  • To emphasize the importance of lipid measurement in cardiovascular risk assessment.
  • To highlight the role of lipid-lowering therapies in CVD prevention.
  • To discuss the targets and agents used in lipid management.

Main Methods:

  • Review of lipid profiles and their association with cardiovascular disease.
  • Assessment of the role of lifestyle modifications and pharmacotherapy in lipid management.
  • Evaluation of different classes of lipid-lowering drugs.

Main Results:

  • Lipid measurements are essential for individuals with existing CVD or type 2 diabetes, and for general cardiovascular risk assessment.
  • Lifestyle interventions are important, but pharmacotherapy is the cornerstone of lipid-lowering treatment.
  • Statins are primary agents, with ezetimibe, fibrates, and nicotinic acid offering alternative or complementary roles.

Conclusions:

  • Effective lipid management is vital for reducing cardiovascular disease burden.
  • Targeting LDL cholesterol and triglycerides, while considering HDL cholesterol, is key.
  • A combination of lifestyle changes and pharmacologic interventions ensures optimal patient outcomes.

Related Experiment Videos